Literature DB >> 26595879

Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol.

Jorge Juárez1, Ángeles Guerrero-Álvarez1.   

Abstract

Prenatal alcohol treatment (PA) produces a decrease in dopaminergic neuron activity in the ventral tegmental area, an alteration that is alleviated with methylphenidate treatment. Evidence exists that PA also produces hyperactivity, inattention and enhanced impulsivity, behavioral alterations that have been related to dopaminergic and noradrenergic functions. The purpose of this work was to study the effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent male rats prenatally exposed to alcohol. Pregnant Wistar rats were exposed to either alcohol or an isocaloric solution from Days 8 to 20 of gestation. Starting at 24 postnatal days, male offspring were tested for motor activity and trained in a delay-discounting task for impulsivity assessment before, and during, treatment with either 3 mg/kg i.p. of methylphenidate, 2 mg/kg i.p. of atomoxetine, or saline i.p. The group prenatally exposed to alcohol showed higher motor activity and more frequent choices of immediate, but small, rewards than the control group; a finding indicative of higher impulsivity. Atomoxetine reduced both motor activity and impulsivity. In contrast, methylphenidate had only a mild effect on impulsivity. Results suggest an important participation of noradrenergic transmission in cognitive impulsivity and hyperactivity in preadolescent rats with previous alterations in these behaviors. Dopaminergic participation in these behaviors is partially supported by the present findings on the basis of the effects of methylphenidate. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26595879     DOI: 10.1037/bne0000109

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  5 in total

Review 1.  Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.

Authors:  Frank N Perkins; Kevin B Freeman
Journal:  Pharmacol Biochem Behav       Date:  2017-06-27       Impact factor: 3.533

2.  Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Mohammad Abdollahi; Mansour Heidari; Zahra Madjd
Journal:  Neurotox Res       Date:  2017-01-11       Impact factor: 3.911

3.  The Therapeutic Efficacy of Environmental Enrichment and Methylphenidate Alone and in Combination after Controlled Cortical Impact Injury.

Authors:  Jacob B Leary; Corina O Bondi; Megan J LaPorte; Lauren J Carlson; Hannah L Radabaugh; Jeffrey P Cheng; Anthony E Kline
Journal:  J Neurotrauma       Date:  2016-05-09       Impact factor: 5.269

4.  Differential effects of d-amphetamine and atomoxetine on risk-based decision making of Lewis and Fischer 344 rats.

Authors:  Jenny E Ozga-Hess; Karen G Anderson
Journal:  Behav Pharmacol       Date:  2019-10       Impact factor: 2.293

5.  Lingering Effects of Prenatal Alcohol Exposure on Basal and Ethanol-Evoked Expression of Inflammatory-Related Genes in the CNS of Adolescent and Adult Rats.

Authors:  Tamara L Doremus-Fitzwater; Steven L Youngentob; Lisa Youngentob; Anny Gano; Andrew S Vore; Terrence Deak
Journal:  Front Behav Neurosci       Date:  2020-06-29       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.